Relationship between functional Nrf2 gene promoter polymorphism and sperm DNA damage in male infertility.


Journal

Systems biology in reproductive medicine
ISSN: 1939-6376
Titre abrégé: Syst Biol Reprod Med
Pays: England
ID NLM: 101464963

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 21 9 2021
medline: 18 1 2022
entrez: 20 9 2021
Statut: ppublish

Résumé

This study examines the association of the -617 C > A polymorphism in the Nrf2 gene (rs6721961) with male infertility in a Turkish population and determines its functional role in spermatogenesis in correlation with the impact of different levels of DNA damage on the genotypes. A total of 100 infertile men and 100 healthy fertile men were included in the study. Nrf2 genotyping was performed with the PCR-based restriction fragment length gene polymorphism (RFLP-PCR) analysis. According to our results, the Nrf2 CC, CA, and AA genotype distribution frequencies were 58.6%, 38.4%, and 3% in the control group, respectively, and 38%, 48%, and 14% in the infertile men, respectively. The AA genotype was significantly higher in the patient group. In smokers, a significant difference was found in progressive motility values between the genotypes (p = 0.001). Also, sperm progressive motility and concentration decreased significantly in those smokers with the AA genotype; smokers carrying this genotype were also 5.75 times more likely to have oligoasthenozoospermia than those with CC (p < 0.05). There was a significant relationship between the number of cases with high sperm-DNA damage when comparing the frequency of Nrf2 AA genotype carriers with the CC genotype 16.3% vs. 6.9%, respectively (p < 0.001). These results suggest the importance of the Nrf2 gene C > A (rs 6,721,961) polymorphism in the etiology of sperm DNA damage as a risk factor for male infertility. Smokers carrying the AA genotype are more likely to impair seminal parameters through antioxidant mechanisms.

Identifiants

pubmed: 34541983
doi: 10.1080/19396368.2021.1972359
doi:

Substances chimiques

NF-E2-Related Factor 2 0
NFE2L2 protein, human 0
Arylamine N-Acetyltransferase EC 2.3.1.5
NAT2 protein, human EC 2.3.1.5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-412

Auteurs

O Sena Aydos (OS)

Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.

Yunus Yukselten (Y)

Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.
Research Laboratories for Health Science, Y Gen Biotechnology Company Ltd, Ankara, Turkey.

Dunya Aydos (D)

Department of Stem Cells and Regenerative Medicine, Stem Cell Institute, Ankara University Ankara, Turkey.

Asuman Sunguroglu (A)

Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey.

Kaan Aydos (K)

Department of Urology, School of Medicine, Ankara University, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH